Alliance A091102: Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma.
Mark Andrew Dickson
No relevant relationships to disclose
Michelle R. Mahoney
No relevant relationships to disclose
William D. Tap
No relevant relationships to disclose
Sandra P. D'Angelo
No relevant relationships to disclose
Mary Louise Keohan
No relevant relationships to disclose
Brian Andrew Van Tine
No relevant relationships to disclose
Mark Agulnik
No relevant relationships to disclose
Laura E. Horvath
No relevant relationships to disclose
Gary K. Schwartz
No relevant relationships to disclose